These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24042367)

  • 1. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
    Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
    Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
    Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summaries for patients. Does varenicline help people with depression quit smoking?
    Ann Intern Med; 2013 Sep; 159(6):I-36. PubMed ID: 24042380
    [No Abstract]   [Full Text] [Related]  

  • 5. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
    Tonstad S; Davies S; Flammer M; Russ C; Hughes J
    Drug Saf; 2010 Apr; 33(4):289-301. PubMed ID: 20297861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
    JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
    Nakamura M; Oshima A; Fujimoto Y; Maruyama N; Ishibashi T; Reeves KR
    Clin Ther; 2007 Jun; 29(6):1040-56. PubMed ID: 17692720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
    Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
    Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
    Wong J; Abrishami A; Yang Y; Zaki A; Friedman Z; Selby P; Chapman KR; Chung F
    Anesthesiology; 2012 Oct; 117(4):755-64. PubMed ID: 22890119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
    Tashkin DP; Rennard S; Hays JT; Ma W; Lawrence D; Lee TC
    Chest; 2011 Mar; 139(3):591-599. PubMed ID: 20864613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
    Ebbert JO; Hughes JR; West RJ; Rennard SI; Russ C; McRae TD; Treadow J; Yu CR; Dutro MP; Park PW
    JAMA; 2015 Feb; 313(7):687-94. PubMed ID: 25688780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Chengappa KN; Perkins KA; Brar JS; Schlicht PJ; Turkin SR; Hetrick ML; Levine MD; George TP
    J Clin Psychiatry; 2014 Jul; 75(7):765-72. PubMed ID: 25006684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.